<DOC>
	<DOCNO>NCT00146016</DOCNO>
	<brief_summary>* Adding Amantadine standard anti-viral treatment improve sustain response rate patient chronic hepatitis C</brief_summary>
	<brief_title>Study Chronic Hepatitis C Treatment With Interferon Alpha , Ribavirin Amantadine Naive Patients</brief_title>
	<detailed_description>The CIRA-study double blind , placebo control , randomise , multicentre study previously untreated patient suffer chronic hepatitis C compare double therapy , consist ( PEG- ) interferon alpha 2b ( ( PEG ) Intron-A® ) ribavirin ( Rebetol® ) , triple therapy , consist ( PEG- ) interferon alpha 2b , ribavirin amantadine , 52 week . Follow-up complete week 104 . 150 Subjects per treatment group include . Patients stratify randomisation accord genotype ( 1 versus non-1 ) . Viral load discriminate factor . The aim investigate efficacy adjunct amantadine currently use combination therapy interferon alpha ribavirin .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Ribavirin</mesh_term>
	<mesh_term>Amantadine</mesh_term>
	<mesh_term>Interferon-alpha</mesh_term>
	<criteria>AntiHCV positivity &gt; 6 month ALT and/or AST elevation least previous 6 month Positive HCVRNA Liver biopsy within one year start therapy non cirrhosis . In case know cirrhosis , liver biopsy necessary Intention treat participate treatment Obtained write informed consent Age &lt; 18 year Pregnancy intention get pregnant within 12 month period treatment 6 month discontinuation therapy , adequate contraception , lactation Men practice willing practice acceptable method contraception treatment period 6 month discontinuation therapy Life expectancy &lt; 1 year Child Pugh B C ( Appendix III ) Creatinine &gt; 150 μmol/L &gt; 1.70 mg/dl Haemoglobulin &lt; 6.5 mmol/l &lt; 10.5 g/dl White blood cell count &lt; 2,5 x 109/L , neutrophil &lt; 1,5 x 109/L Platelet count &lt; 70 x 109/L HIV positivity Chemotherapy , systematical antiviral treatment 6 month prior study entry Other serious disease ( e.g . malignancy , uncontrolled myocardial disease severe arrhythmia ) Active uncontrolled psychiatric disorder suicidal leanings Patients history uncontrolled seizure significant CNS dysfunction Any condition opinion ( co ) investigator might interfere evaluation study objective</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2005</verification_date>
	<keyword>Chronic Hepatitis C</keyword>
	<keyword>Amantadine</keyword>
	<keyword>Triple therapy</keyword>
</DOC>